IBDEI1ZI ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1654,0)
 ;;=OCCUPATIONAL^17^161
 ;;^UTILITY(U,$J,358.4,1655,0)
 ;;=OTHER^18^161
 ;;^UTILITY(U,$J,358.4,1656,0)
 ;;=PLEURAL DISEASE^20^161
 ;;^UTILITY(U,$J,358.4,1657,0)
 ;;=INFECTIOUS DISEASES^12^161
 ;;^UTILITY(U,$J,358.4,1658,0)
 ;;=NEUROMUSCULAR/SKELETAL^16^161
 ;;^UTILITY(U,$J,358.4,1659,0)
 ;;=GASTROINTESTINAL^8^161
 ;;^UTILITY(U,$J,358.4,1660,0)
 ;;=HEPATIC & BILIARY^11^161
 ;;^UTILITY(U,$J,358.4,1661,0)
 ;;=NEUROLOGIC^15^161
 ;;^UTILITY(U,$J,358.4,1662,0)
 ;;=SKIN^26^161
 ;;^UTILITY(U,$J,358.4,1663,0)
 ;;=PSYCHIATRIC & BEHAVIORAL^21^161
 ;;^UTILITY(U,$J,358.4,1664,0)
 ;;=CANCER^2^161
 ;;^UTILITY(U,$J,358.4,1665,0)
 ;;=RADIATION^22^161
 ;;^UTILITY(U,$J,358.4,1666,0)
 ;;=SKELETAL^25^161
 ;;^UTILITY(U,$J,358.4,1667,0)
 ;;=PAIN^19^161
 ;;^UTILITY(U,$J,358.4,1668,0)
 ;;=SUTURES/DRESSINGS^28^161
 ;;^UTILITY(U,$J,358.4,1669,0)
 ;;=COMPLICATIONS^4^161
 ;;^UTILITY(U,$J,358.4,1670,0)
 ;;=SLEEP DISORDERS^27^161
 ;;^UTILITY(U,$J,358.4,1671,0)
 ;;=COMMON PULMONARY DX^1^161
 ;;^UTILITY(U,$J,358.4,1672,0)
 ;;=CVA LATE EFFECTS^5^161
 ;;^UTILITY(U,$J,358.4,1673,0)
 ;;=SCI/PARALYTIC SYNDROMES^23^161
 ;;^UTILITY(U,$J,358.4,1674,0)
 ;;=VACCINATIONS^13^162
 ;;^UTILITY(U,$J,358.4,1675,0)
 ;;=INJECTION^7^162
 ;;^UTILITY(U,$J,358.4,1676,0)
 ;;=EDUCATION/TRAINING^3^162
 ;;^UTILITY(U,$J,358.4,1677,0)
 ;;=COUNSELING^2^162
 ;;^UTILITY(U,$J,358.4,1678,0)
 ;;=EVALUATIONS^4^162
 ;;^UTILITY(U,$J,358.4,1679,0)
 ;;=SPINAL INJECTION CODES^9^162
 ;;^UTILITY(U,$J,358.4,1680,0)
 ;;=SUPPLIES^10^162
 ;;^UTILITY(U,$J,358.4,1681,0)
 ;;=TREATMENT PROCEDURES^11^162
 ;;^UTILITY(U,$J,358.4,1682,0)
 ;;=TRIGGER POINT INJECTIONS^12^162
 ;;^UTILITY(U,$J,358.4,1683,0)
 ;;=HOME VISIT-ESTABLISHED PT^5^162
 ;;^UTILITY(U,$J,358.4,1684,0)
 ;;=HOME VISIT-NEW PT^6^162
 ;;^UTILITY(U,$J,358.4,1685,0)
 ;;=ON-LINE MEDICAL EVAL^8^162
 ;;^UTILITY(U,$J,358.4,1686,0)
 ;;=ACUPUNCTURE^1^162
 ;;^UTILITY(U,$J,358.4,1687,0)
 ;;=OTHER/MISC DIAGNOSES^11^163
 ;;^UTILITY(U,$J,358.4,1688,0)
 ;;="E" CODES-SECONDARY ONLY^5^163
 ;;^UTILITY(U,$J,358.4,1689,0)
 ;;=ULCER^15^163
 ;;^UTILITY(U,$J,358.4,1690,0)
 ;;=MUSCULOSKELETAL^9^163
 ;;^UTILITY(U,$J,358.4,1691,0)
 ;;=NEPHRO/GU/GI^10^163
 ;;^UTILITY(U,$J,358.4,1692,0)
 ;;=CARDIOVASCULAR^2^163
 ;;^UTILITY(U,$J,358.4,1693,0)
 ;;=PARAPLEGIA^12^163
 ;;^UTILITY(U,$J,358.4,1694,0)
 ;;=QUADRAPLEGIA^13^163
 ;;^UTILITY(U,$J,358.4,1695,0)
 ;;=MENTAL HEALTH^8^163
 ;;^UTILITY(U,$J,358.4,1696,0)
 ;;=SIGNS,SYMPTOMS,CONDITIONS^14^163
 ;;^UTILITY(U,$J,358.4,1697,0)
 ;;=BLINDNESS^1^163
 ;;^UTILITY(U,$J,358.4,1698,0)
 ;;=CVA LATE EFFECT^3^163
 ;;^UTILITY(U,$J,358.4,1699,0)
 ;;=DIPLEGIA/MONO/HEMIPLEGIA^4^163
 ;;^UTILITY(U,$J,358.4,1700,0)
 ;;=HEPATITIS C^6^163
 ;;^UTILITY(U,$J,358.4,1701,0)
 ;;=MALNUTRITION^7^163
 ;;^UTILITY(U,$J,358.4,1702,0)
 ;;=NEW PT-OFFICE^3^164
 ;;^UTILITY(U,$J,358.4,1703,0)
 ;;=ESTABLISHED PT-OFFICE^1^164
 ;;^UTILITY(U,$J,358.4,1704,0)
 ;;=CONSULTATIONS^5^164
 ;;^UTILITY(U,$J,358.4,1705,0)
 ;;=RESPIRATORY^8^165
 ;;^UTILITY(U,$J,358.4,1706,0)
 ;;=SLEEP TESTING AND EVAL^9^165
 ;;^UTILITY(U,$J,358.4,1707,0)
 ;;=PULMONARY FUNCTION TESTS^7^165
 ;;^UTILITY(U,$J,358.4,1708,0)
 ;;=ABG/OX/TRANSCUTANEUOUS^1^165
 ;;^UTILITY(U,$J,358.4,1709,0)
 ;;=HOME OXYGEN CLINIC^6^165
 ;;^UTILITY(U,$J,358.4,1710,0)
 ;;=CPAP^2^165
 ;;^UTILITY(U,$J,358.4,1711,0)
 ;;=EDUCATION/TRAINING^3^165
 ;;^UTILITY(U,$J,358.4,1712,0)
 ;;=PULMONARY DIAGNOSES^1^166
 ;;^UTILITY(U,$J,358.4,1713,0)
 ;;=SLEEP DX PRELIMINARY^2^166
 ;;^UTILITY(U,$J,358.4,1714,0)
 ;;=SLEEP DX CONFIRMED^3^166
 ;;^UTILITY(U,$J,358.4,1715,0)
 ;;=NEW PATIENT^2^167
